For example, in humans, a variant within the dDENN domain of SBF2 leads to a demyelinating neuropathy (Senderek et al., 2003) and a variant within the DENN domain causes a thrombocytopenia without neurological manifestations (Abuzenadah et al., 2013). Here, MADD is linked to Thrombocytopenia.